CN116829166A - 用于治疗乳糜泻的组合物和方法 - Google Patents

用于治疗乳糜泻的组合物和方法 Download PDF

Info

Publication number
CN116829166A
CN116829166A CN202180068658.4A CN202180068658A CN116829166A CN 116829166 A CN116829166 A CN 116829166A CN 202180068658 A CN202180068658 A CN 202180068658A CN 116829166 A CN116829166 A CN 116829166A
Authority
CN
China
Prior art keywords
amino acid
ala
polypeptide
gly
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180068658.4A
Other languages
English (en)
Chinese (zh)
Inventor
I·S·普利茨
C·沃夫
J·B·西格尔
C·E·廷伯格
L·斯特沃特
D·贝克尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WASHINGTON, University of
University of California, San Diego
Original Assignee
WASHINGTON, University of
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WASHINGTON, University of, University of California, San Diego filed Critical WASHINGTON, University of
Publication of CN116829166A publication Critical patent/CN116829166A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202180068658.4A 2020-10-30 2021-10-29 用于治疗乳糜泻的组合物和方法 Pending CN116829166A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063108163P 2020-10-30 2020-10-30
US63/108,163 2020-10-30
PCT/US2021/057197 WO2022094177A1 (en) 2020-10-30 2021-10-29 Compositions and methods for treating celiac sprue disease

Publications (1)

Publication Number Publication Date
CN116829166A true CN116829166A (zh) 2023-09-29

Family

ID=78819631

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180068658.4A Pending CN116829166A (zh) 2020-10-30 2021-10-29 用于治疗乳糜泻的组合物和方法

Country Status (12)

Country Link
US (1) US20250064903A1 (cg-RX-API-DMAC7.html)
EP (1) EP4237554A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023548083A (cg-RX-API-DMAC7.html)
KR (1) KR20230093323A (cg-RX-API-DMAC7.html)
CN (1) CN116829166A (cg-RX-API-DMAC7.html)
AR (1) AR123961A1 (cg-RX-API-DMAC7.html)
AU (1) AU2021368118A1 (cg-RX-API-DMAC7.html)
CA (1) CA3195929A1 (cg-RX-API-DMAC7.html)
CO (1) CO2023006731A2 (cg-RX-API-DMAC7.html)
MX (1) MX2023004807A (cg-RX-API-DMAC7.html)
TW (1) TW202233834A (cg-RX-API-DMAC7.html)
WO (1) WO2022094177A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025068987A1 (en) 2023-09-28 2025-04-03 Takeda Pharmaceutical Company Limited A method of producing a kumamolisin-as polypeptide

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322211A (zh) * 1998-10-05 2001-11-14 武田药品工业株式会社 除去n-末端蛋氨酸的方法
CN106794228A (zh) * 2014-06-16 2017-05-31 内佩泰克斯有限责任公司 用于治疗麸质不耐受和由其引起的病症的组合物和方法
CN107873053A (zh) * 2015-06-08 2018-04-03 华盛顿大学 治疗乳糜泻疾病的组合物和方法
CN110325636A (zh) * 2016-12-22 2019-10-11 Ew营养有限责任公司 稳定的蛋白酶变体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4475707B2 (ja) * 1998-10-05 2010-06-09 武田薬品工業株式会社 N末端メチオニンの除去方法
LT2718434T (lt) 2011-08-10 2018-08-10 University Of Washington Through Its Center For Commercialization Kompozicijos ir būdai, skirti celiakijos gydymui
US10266815B2 (en) * 2013-08-14 2019-04-23 University Of Washington Through Its Center For Commercialization Compositions and methods for treating celiac sprue disease

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1322211A (zh) * 1998-10-05 2001-11-14 武田药品工业株式会社 除去n-末端蛋氨酸的方法
CN106794228A (zh) * 2014-06-16 2017-05-31 内佩泰克斯有限责任公司 用于治疗麸质不耐受和由其引起的病症的组合物和方法
CN107873053A (zh) * 2015-06-08 2018-04-03 华盛顿大学 治疗乳糜泻疾病的组合物和方法
CN110325636A (zh) * 2016-12-22 2019-10-11 Ew营养有限责任公司 稳定的蛋白酶变体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
WINGFIELD, P等: "N-Terminal Methionine Processing", CURR PROTOC PROTEIN SCI, vol. 88, 3 April 2017 (2017-04-03) *
ZHANG等: "Expression of N-Terminal Cysteine Aβ42 and Conjugation to Generate Fluorescent and Biotinylated Aβ42", BIOCHEMISTRY, vol. 60, no. 15, 20 April 2021 (2021-04-20), pages 1191 - 1200 *
邢素婷: "PEP酶催化降解麸质蛋白的机理研究", 中国优秀硕士学位论文全文数据库(电子期刊)工程科技I辑, no. 10, 15 October 2022 (2022-10-15), pages 016 - 333 *

Also Published As

Publication number Publication date
EP4237554A1 (en) 2023-09-06
AU2021368118A1 (en) 2023-05-11
CA3195929A1 (en) 2022-05-05
AR123961A1 (es) 2023-01-25
CO2023006731A2 (es) 2023-06-09
JP2023548083A (ja) 2023-11-15
KR20230093323A (ko) 2023-06-27
WO2022094177A1 (en) 2022-05-05
MX2023004807A (es) 2023-05-10
US20250064903A1 (en) 2025-02-27
TW202233834A (zh) 2022-09-01
AU2021368118A9 (en) 2023-07-06

Similar Documents

Publication Publication Date Title
JP6342802B2 (ja) セリアックスプルー病を治療するための組成物および方法
JP7429907B2 (ja) セリアックスプルー病を治療するための組成物および方法
US20240158774A1 (en) Compositions and Methods for Treating Celiac Sprue Disease
CN105324483A (zh) 工程化苯丙氨酸解氨酶多肽
TW202233834A (zh) 用於治療乳糜瀉的組合物及方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination